Norden Group LLC Becton Dickinson & CO Transaction History

Norden Group LLC

$984 Billion
Q3 2025

A detailed history of Norden Group LLC transactions in Becton Dickinson & CO stock. As of the latest transaction made, Norden Group LLC holds 11,287 shares of BDX stock, worth $2.02 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

11,287

Previous 12,323 8.41%

Holding current value

$2.02 Million

Previous $2.12 Billion 0.47%

% of portfolio

0.21%

Previous 0.23%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 15, 2025	SELL	$172.41 - $199.66 $178,616 - $206,847	-1,036 Reduced 8.41%	11,287 $2.11 Billion
Q2 2025 Jul 15, 2025	BUY	$165.15 - $226.42 $415,187 - $569,219	2,514 Added 25.63%	12,323 $2.12 Billion
Q1 2025 May 07, 2025	SELL	$222.79 - $249.08 $284,948 - $318,573	-1,279 Reduced 11.53%	9,809 $2.25 Billion
Q4 2024 Feb 05, 2025	BUY	$220.02 - $243.75 $217,819 - $241,312	990 Added 9.8%	11,088 $2.52 Billion
Q3 2024 Oct 17, 2024	BUY	$221.47 - $242.41 $1.85 Million - $2.02 Million	8,345 Added 476.04%	10,098 $2.43 Billion
Q2 2024 Aug 06, 2024	SELL	$225.07 - $246.17 $107,583 - $117,669	-478 Reduced 21.43%	1,753 $410 Million
Q1 2024 Apr 30, 2024	SELL	$233.45 - $247.73 $11.6 Million - $12.3 Million	-49,703 Reduced 95.7%	2,231 $552 Million
Q1 2024 Apr 19, 2024	BUY	$233.45 - $247.73 $11.6 Million - $12.3 Million	49,559 Added 2086.69%	51,934 $12.9 Billion
Q4 2023 Feb 05, 2024	SELL	$232.24 - $267.23 $213,660 - $245,851	-920 Reduced 27.92%	2,375 $579 Million
Q3 2023 Nov 06, 2023	BUY	$254.9 - $283.59 $839,895 - $934,429	3,295 New	3,295 $852 Million

Others Institutions Holding BDX

# of Institutions

1,754

Shares Held

260M

Call Options Held

1.82M

Put Options Held

696K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $51B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Norden Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Norden Group LLC with notifications on news.

Account